Inclisiran's effect is primarily a reduction in which lipid parameter?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Inclisiran's effect is primarily a reduction in which lipid parameter?

Inclisiran lowers LDL cholesterol as its primary effect. It’s an siRNA that blocks the production of PCSK9 in the liver. PCSK9 normally promotes the degradation of LDL receptors on hepatocytes, which puts a brake on the liver’s ability to clear LDL from the blood. With less PCSK9 made, more LDL receptors are available to remove LDL particles from circulation, producing a substantial decrease in LDL-C. Triglycerides and HDL-C aren’t the main targets of this therapy, so their changes are smaller in comparison, though some modest shifts in other lipid measures can occur.

Inclisiran lowers LDL cholesterol as its primary effect. It’s an siRNA that blocks the production of PCSK9 in the liver. PCSK9 normally promotes the degradation of LDL receptors on hepatocytes, which puts a brake on the liver’s ability to clear LDL from the blood. With less PCSK9 made, more LDL receptors are available to remove LDL particles from circulation, producing a substantial decrease in LDL-C. Triglycerides and HDL-C aren’t the main targets of this therapy, so their changes are smaller in comparison, though some modest shifts in other lipid measures can occur.

More practice questions